Delivery Order SPE2DB20D3103-SPE2DB24FQ0L9
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.40 Firm Fixed Price delivery order is for the supply of Emtricitabine-Tenofovir 200-300 mg pharmaceutical products. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of emtricitabine-tenofovir 200-300 mg medications. The $4,524.03 firm fixed-price delivery order has a period of performance through March 30, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,210.20, is a delivery order contract for the supply of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has a completion date of May 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,380.95 delivery order contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. This award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,371.76 Firm Fixed Price Delivery Order contract is for the provision of Emtricitabine-Tenofovir 200-300mg medication. The award, which has an ultimate completion date of August 3, 2023, falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,030.97. The contract was awarded by the Defense Logistics Agency (DLA) on July 6, 2022, with a completion date of July 7, 2022. The contract is for the delivery of emtricitabine-tenofovir 200-300mg medications, a critical pharmaceutical product used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,050.83 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB24FN0X3) is for the supply of emtricitabine-tenofovir 200-300 mg tablets. The award has a completion date of March 20, 2024 and does not include any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.56 firm fixed-price delivery order is for the supply of Emtricitabine-Tenofovir 200-300mg medication, with a performance period through December 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.39 Firm Fixed Price Delivery Order (Contract #: SPE2DB20D1109|SPE2DB23FN23R) is for the delivery of Emtricitabine-Tenofovir 200-300mg medications, with a completion date of December 28, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...